Effects of nonsteroidal anti-inflammatory drugs on glutathione S-transferases of the rat digestive tract

Carcinogenesis

Volumn 18, Issue 3, 1997, Pages 485-490

  Van Lieshout, Esther M M ^a   Tiemessen, Dorien M ^a   Peters, Wilbert H M ^a   Jansen, Jan B M J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ACETYLSALICYLIC ACID; GLUTATHIONE; GLUTATHIONE TRANSFERASE; IBUPROFEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; SULINDAC;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVITY; ENZYME INDUCTION; ESOPHAGUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOBLOTTING; INTESTINE; LIVER; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STOMACH;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; ASPIRIN; CYTOSOL; DIGESTIVE SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; ESOPHAGUS; GLUTATHIONE; GLUTATHIONE TRANSFERASE; IBUPROFEN; INDOMETHACIN; INTESTINES; ISOENZYMES; LIVER; MALE; ORGAN SPECIFICITY; PIROXICAM; RATS; RATS, WISTAR; STOMACH; SUBSTRATE SPECIFICITY; SULINDAC;

EID: 0031408199     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.3.485     Document Type: Article

References (36)

1. Brogden, R.N., Heel, R.C., Speight, T.M. and Avery, G. (1978) Sulindac: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. Drugs, 16, 97-114.
2. Giardiello, F.M. (1994) Sulindac and polyp regression. Cancer Metastas. Rev., 13, 279-283.
3. Giardiello, F.M., Hamilton, S.R., Krush, A.J., Piantadosi, S., Hylind, L.M., Celano, P., Booker, S.V., Robinson, C.R. and Offerhaus, G.J.A. (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328, 1313-1316.
4. Labayle, D., Fischer, D., Vielh, P., Drouhin, F., Pariente, A., Bories, C., Duhamel, O., Trousset, M. and Attali, P. (1991) Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology, 101, 635-639.
5. Ladenheim, J., Garcia, G., Titzer, D., Herzenberg, H., Lavori, P., Edson, R. and Omary, M.B. (1995) Effect of sulindac on sporadic colonic polyps. Gastroenterology, 108, 1083-1087.
6. Rosenberg, L., Palmer, J.R., Zauber, A.G., Warshauer, M.E., Stolley, J.D. and Shapiro, S.A. (1991) A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J. Natl Cancer Inst., 83, 355-358.
7. Thun, M.J., Namboodiri, M.M. and Heath, C.W. (1991) Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325, 1593-1596.
8. Thun, J.M., Namboodiri, M.M., Calle, E.E., Flanders, J.D. and Heath, C.W. (1993) Aspirin use and risk of fatal cancer. Cancer Lett., 53, 1322-1327.
9. Kune, G.A., Kune, S. and Watson, L.F. (1988) Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res., 48, 4399-4404.
10. Paganini-Hill, A., Hsu, G., Ross, R.K. and Henderson, B.E. (1991) Aspirin use and incidence of large-bowel cancer in a California retirement community. J. Natl Cancer. Inst., 83, 1182-1183.
11. Turner, D. and Berkel, H.J. (1993) Nonsteroidal anti-inflammatory drugs for the prevention of colon cancer. Can. Med. Assoc. J., 149, 595-602.
12. Earnest, D.L., Hixson, L.J. and Alberts, D.S. (1992) Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention. J. Cell. Biochem., Suppl. 16I, 136-166.
13. Reddy, B.S., Tokuno, K., Kulkarni, N., Aligia, C. and Kelloff, G. (1992) Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis, 13, 1019-1023.
14. Jalbert, G. and Castonguay, A. (1992) Effects of NSAID's on NNK-induced pulmonary and gastric tumorigenesis in A/J mice. Cancer Lett., 66, 21-28.
15. Narisawa, T., Sato, M., Tani, M., Kudo, T. and Guo, A. (1981) Inhibition of development of methylnitrosurea-induced rat colon tumours by indomethacin treatment. Cancer Res., 41, 1954-1957.
16. Tanaka, T., Kojima, T., Yoshimi, N., Sugie, S. and Mori, H. (1991) Inhibitory effect of the non-steroidal anti-inflammatory drug indomethacin on the naturally occurring carcinogen, 1-hydroxyanthraquinone in male ACI/N rats. Carcinogenesis, 12, 1949-1952.
17. Pollard, M. and Luckert, P.H. (1984) Effect of piroxicam in primary intestinal tumours induced in rats by N-methylnitrosurea. Cancer Lett., 25, 117-121.
18. Rao, C.V., Tokuno, K., Rigotti, J., Zang, E., Kelloff, G. and Reddy, B.S. (1991) Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, α-difluoromethylornithine, 16α-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res., 51, 4528-4534.
19. Reddy, B.S., Nayini, J., Tokuno, K., Rigotti, J., Zang, E. and Kelloff, G. (1990) Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,1,-α-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res., 50, 2562-2568.
20. Takahashi, M., Hasegawa, T., Furukawa, F., Okamiya, H., Shinoda, K., Imaida, K., Toyoda, K. and Hayashi, Y. (1991) Enhanced lipid peroxidation in rat gastric mucosa caused by NaCl. Carcinogenesis, 12, 2201-2204.
21. McCormick, D.L., Madigan, M.J. and Moon, R.C. (1985) Modulation of rat mammary carcinogenesis by indomethacin. Cancer Res., 45, 1803-1808.
22. Grubbs, C.J., Juliana, M.M., Eto, I., Casebolt, T., Whitaker, L.M., Canfield, G.J., Manczak, M., Steele, V.E. and Kelloff, G.J. (1993) Chemoprevention by indomethacin in N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder tumours. Anticancer Res., 13, 33-36.
23. Shibata, M.A., Hasegawa, R., Shirai, T., Takesada, Y. and Fukushima, S. (1993) Chemoprevention by indomethacin of tumour promotion in a rat urinary bladder carcinogenesis model. Int. J. Cancer, 55, 1011-1017.
24. Taton, G., Servais, P., and Galand, P. (1990) Modulation by indomethacin or prostaglandin E2 of the incidence of diethylnitrosamine-induced glutamyltranspeptidase positive foci in rat liver. Jpn. J. Cancer. Res., 81, 747-753.
25. Tanaka, T., Kojima, T., Okomura, A., Sugie, S. and Mori, H. (1993) Inhibitory effect of the non-steroidal anti-inflammatory drugs, indomethacin and piroxicam on 2-acetaminofluorene-induced hepatocarcinogenesis in male ACI/N rats. Cancer Lett., 68, 111-118.
26. Rubio, C.A. (1984) Antitumoral activity of indomethacin on experimental oesophageal tumours. J. Natl Cancer Inst., 72, 705-707.
27. Rubio, C.A. (1986) Further studies on the therapeutic effect of indomethacin on oesophageal tumours. Cancer, 58, 1029-1031.
28. Pollard, M. and Luckert, P.H. (1983) Prolonged antitumor effect of indomethacin on autochthonous intestinal tumours in rats. J. Natl Cancer Inst., 70, 1103-1105.
29. Reddy, B.S., Maruyama, H. and Kelloff, G. (1987) Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumour development. Cancer Res., 47, 5340-5346.
30. Pollard, M., Luckert, P.H. and Schmidt, M.A. (1983) The suppressive effect of piroxicam in autochthonous intestinal tumours in the rat. Cancer Lett., 21, 57-6.
31. Kudo, T., Narisawa, T. and Abo, S. (1980) Antitumour activity of indomethacin on methylazoxymethanol-induced large bowel tumours in rats. Jpn J. Cancer Res., 71, 260-264.
32. Reddy, B. S., Rao, C.V., Rivenson, A. and Kelloff, G. (1993) Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis, 14, 1493-1497.
33. Davis, A.E. and Patterson, F. (1994) Aspirin reduces the incidence of colonic carcinoma in the dimethylhydrazine rat animal model. Aust. N. Z. J. Med., 24, 301-303.
34. Mereto, E., Frencia, L. and Gjia, M. (1994) Effect of aspirin on incidence and growth of aberrant crypt foci induced in the rat colon by 1,2-dimethylhydrazine. Cancer Lett., 76, 5-9.
35. Klän, R., Knispel, H.H. and Meier, T. (1993) Acetylsalicylic acid inhibition of N-butyl-(4-hydroxyl)nitrosamine-induced bladder carcinogenesis in rats. J. Cancer Res. Clin. Oncol., 119, 482-485.
36. Rao, C.V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V. and Reddy, B.S. (1995) Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res., 55, 1464-1472.